XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments.

T. Bagratuni, P. Wu, D. Gonzalez de Castro, E.L. Davenport, N.J. Dickens, B.A. Walker, K. Boyd, D.C. Johnson, W. Gregory, G.J. Morgan, F.E. Davies

Research output: Contribution to journalArticlepeer-review

84 Citations (Scopus)

Fingerprint

Dive into the research topics of 'XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds